From the Fight Colorectal Cancer, this blog post written by Dr. Tom Marsilje, stage IV survivor & cancer drug discovery scientist, addresses what Adoptive Cell Transfer (ACT) of Tumor-Infiltrating Lymphocytes (TILs) are and how they can be used and personalized to fight cancer.
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us